BioTech Sphere Research, a unit of NeoNexus Healthcare Pvt Ltd, is making waves in global healthcare with its deepening commitment to rare disease research, particularly for underserved populations in India and beyond. Under the umbrella of its flagship initiative Project Phoenix, the organization is breaking ground by combining grassroots healthcare innovation with international research collaboration.
A Global Vision for Rare Disease Equity
In partnership with the Global Alliance for Genomics and Health (GA4GH), BioTech Sphere Research is actively contributing to the Rare Disease Workstream — a collaborative network that drives ethical, interoperable genomic research frameworks worldwide.
This vision aligns with BioTech’s broader goal: bringing early diagnostics, genomic literacy, and digital monitoring tools to Tier 3 and Tier 4 cities, often overlooked in national healthcare programs.
“We believe the future of rare disease diagnostics lies in real-time rural data, community ownership, and global collaboration.”
— Aryan Chaudhary, Director, BioTech Sphere Research
Research Declarations & Global Recognition
BioTech’s dedication to impactful research is backed by significant academic and data-driven achievements:
- 442.4+ Research Interest Score
- 19,067+ Reads across indexed publications
- 70+ Countries Engaged with BioTech-authored research
- 54+ Published Studies, reviews, and preprints in rare disease, rural health innovation, and digital diagnostics.
Additionally, BioTech is a signatory of the San Francisco Declaration on Research Assessment (DORA), reinforcing its commitment to responsible metrics and transparent science dissemination.
Latest Announcements
First Peer-Reviewed Paper with Springer Nature
BioTech Sphere Research has officially published its first peer-reviewed review paper with Springer Nature, marking a milestone in its formal scientific contributions to global rare disease literature.
Contribution to a Taylor & Francis Book Series
Further extending its impact, the organization has also contributed to an upcoming Taylor & Francis book series centered on innovations in precision medicine and rural healthcare transformation.
These milestones affirm BioTech’s positioning as a thought leader in merging health equity, technology, and community-led healthcare models.
The Meerut ACM Rare Disease Research Hub
Through its academic collaboration with the Meerut ACM Professional Chapter, BioTech has established the Meerut Rare Disease Hub — a center focused on computational biology, epidemiology, and smart diagnostics for low-resource environments. This interdisciplinary hub is working closely with local institutions and data scientists to unlock new insights into rare, chronic, and environmental-linked diseases.
Strategic Partnerships & Institutional Engagement
BioTech Sphere Research is proudly affiliated with major global and national initiatives, including:
- GA4GH (Global Alliance for Genomics and Health)
- IRDiRC (International Rare Diseases Research Consortium)
- ECHAlliance
- Google for Education
- Skill India | MSME | Start-Up India | Village Capital
These partnerships amplify the reach and credibility of BioTech’s mission to democratize research access and data utility for rural populations.
Join Our Movement
BioTech Sphere Research invites collaborations from researchers, digital health innovators, and policy organizations focused on rare diseases, digital therapeutics, and inclusive health access.
